Back to Propel Bio Management, LLC
Q2 2026 13F filing
Updated 31 days ago29 disclosed positions worth $191.1M
Portfolio value
$191.1M
Total holdings
29
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-08-13
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | P PAGP PLAINS GP HOLDINGS LP-CL | $30.9M | 1.27M | 16.16% | — |
| 2 | A ACHV ACHIEVE LIFE SCIENCES INC | $26.3M | 4.03M | 13.79% | — |
| 3 | C CORT CORCEPT THERAPEUTICS INC | $11.9M | 136.5K | 6.21% | — |
| 4 | P PHAT PHATHOM PHARMACEUTICALS I | $11.4M | 1.05M | 5.96% | — |
| 5 | D DCTH DELCATH SYSTEMS INC | $11M | 871.5K | 5.74% | — |
| 6 | M MIST MILESTONE PHARMACEUTICALS | $10M | 7.43M | 5.21% | — |
| 7 | C CMPS COMPASS PATHWAYS PLC | $8.1M | 573.1K | 4.24% | — |
| 8 | ? N/A KYVERNA THERAPEUTICS INC | $7.9M | 883.2K | 4.12% | — |
| 9 | ? N/A ARTIVA BIOTHERAPEUTICS IN | $6.8M | 696.4K | 3.54% | — |
| 10 | A ABEO ABEONA THERAPEUTICS INC | $6.1M | 983.1K | 3.18% | — |
| 11 | A AQST AQUESTIVE THERAPEUTICS IN | $6M | 1.44M | 3.14% | — |
| 12 | ? N/A PALISADE BIO INC | $5.4M | 2.58M | 2.82% | — |
| 13 | ? N/A IMMUNIC INC | $5M | 325.0K | 2.61% | — |
| 14 | I IVEVF INVENTIVA SA - ADR | $4.8M | 1.28M | 2.53% | — |
| 15 | S SABSW SAB BIOTHERAPEUTICS INC | $4.2M | 1.08M | 2.20% | — |
| 16 | O OBIO ORCHESTRA BIOMED HOLDINGS | $3.9M | 896.7K | 2.02% | — |
| 17 | C CLDX CELLDEX THERAPEUTICS INC | $3.9M | 103.7K | 2.02% | — |
| 18 | J JPM-PM ZEVRA THERAPEUTICS INC | $3.6M | 253.5K | 1.90% | — |
| 19 | O OCFC OCULAR THERAPEUTIX INC | $3.5M | 358.0K | 1.84% | — |
| 20 | F FDMT 4D MOLECULAR THERAPEUTICS IN | $3.4M | 252.7K | 1.76% | — |
| 21 | O OVID OVID THERAPEUTICS INC | $3M | 1.12M | 1.57% | — |
| 22 | ? N/A EYEPOINT INC | $2.7M | 191.7K | 1.43% | — |
| 23 | ? N/A UPSTREAM BIO INC | $2.4M | 350.4K | 1.27% | — |
| 24 | S SCYX SCYNEXIS INC | $2.2M | 543.5K | 1.16% | — |
| 25 | S SLNCF SILENCE THERAPEUTICS PLC | $2.1M | 191.7K | 1.10% | — |
| 26 | L LONA LEONABIO INC | $1.4M | 149.3K | 0.72% | — |
| 27 | M MAZE MAZE THERAPEUTICS INC | $1.3M | 43.8K | 0.68% | — |
| 28 | C CRVS CORVUS PHARMACEUTICALS INC | $1.1M | 70.4K | 0.55% | — |
| 29 | S SGMT SAGIMET BIOSCIENCES INC-A | $973K | 125.9K | 0.51% | — |